Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 31.5.20191 Min. Lesezeit
Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations; Public Workshop
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA, we) is announcing the following pubic workshop entitled "Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations." This public workshop is convened by Duke University's Robert J. Margolis, MD, Center for Health Policy and supported by a cooperative agreement with FDA. The purpose of the public workshop is to capture stakeholder experiences with risk-based approaches to monitoring of clinical investigations and gather stakeholder input on opportunities to further the implementation of risk-based approaches to monitoring.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →